Difference between revisions of "Template:Antidepressants"
Jump to navigation
Jump to search
blackwiki>DASHBot m (Bot: Bypassing redirects in navboxes, in order to improve article navigability;details/shutoff) |
(Less blocky dots (like other Wikipedia templates) that also handle linewrapping. Also, <noinclude> immediately after end of template code.) |
||
| Line 11: | Line 11: | ||
| group1 = <small>[[Selective serotonin reuptake inhibitor|Selective Serotonin Reuptake Inhibitor]]s (SSRIs)</small> | | group1 = <small>[[Selective serotonin reuptake inhibitor|Selective Serotonin Reuptake Inhibitor]]s (SSRIs)</small> | ||
| − | | list1 = [[Alaproclate]] | + | | list1 = [[Alaproclate]]{{·}} [[Citalopram]]{{·}} [[Escitalopram]]{{·}} [[Femoxetine]]{{·}} [[Fluoxetine]]{{·}} [[Fluvoxamine]]{{·}} [[Indalpine]]{{·}} [[Ifoxetine]]{{·}} [[Litoxetine]]{{·}} [[Lubazodone]]{{·}} [[Paroxetine]]{{·}} [[Pirandamine]]{{·}} [[Seproxetine]]{{·}} [[Sertraline]]{{·}} [[Vilazodone]]{{·}} [[Zimelidine]] |
| group2 = <small>[[Serotonin-norepinephrine reuptake inhibitor|Serotonin-Norepinephrine Reuptake Inhibitor]]s (SNRIs)</small> | | group2 = <small>[[Serotonin-norepinephrine reuptake inhibitor|Serotonin-Norepinephrine Reuptake Inhibitor]]s (SNRIs)</small> | ||
| − | | list2 = [[Bicifadine]] | + | | list2 = [[Bicifadine]]{{·}} [[Clovoxamine]]{{·}} [[Desvenlafaxine]]{{·}} [[Duloxetine]]{{·}} [[Levomilnacipran]]{{·}} [[Milnacipran]]{{·}} [[Sibutramine]]{{·}} [[Venlafaxine]] |
| group3 = <small>[[Serotonin-norepinephrine-dopamine reuptake inhibitor|Serotonin-Norepinephrine-Dopamine Reuptake Inhibitor]]s (SNDRIs)</small> | | group3 = <small>[[Serotonin-norepinephrine-dopamine reuptake inhibitor|Serotonin-Norepinephrine-Dopamine Reuptake Inhibitor]]s (SNDRIs)</small> | ||
| − | | list3 = [[Brasofensine]] | + | | list3 = [[Brasofensine]]{{·}} [[BTS-74,398]]{{·}} [[Cocaine]]{{·}} [[Diclofensine]]{{·}} [[DOV-21,947]]{{·}} [[DOV-102,677]]{{·}} [[DOV-216,303]]{{·}} [[EXP-561]]{{·}} [[Fezolamine]]{{·}} [[JNJ-7,925,476]]{{·}} [[NS-2359]]{{·}} [[PRC200-SS]]{{·}} [[Pridefrine]]{{·}} [[SEP-225,289]]{{·}} [[SEP-227,162]]{{·}} [[Tesofensine]] |
| group4 = <small>[[Norepinephrine reuptake inhibitor|Norepinephrine Reuptake Inhibitor]]s (NRIs)</small> | | group4 = <small>[[Norepinephrine reuptake inhibitor|Norepinephrine Reuptake Inhibitor]]s (NRIs)</small> | ||
| − | | list4 = [[Atomoxetine|Atomoxetine/Tomoxetine]] | + | | list4 = [[Atomoxetine|Atomoxetine/Tomoxetine]]{{·}} [[Binedaline]]{{·}} [[Ciclazindol]]{{·}} [[Esreboxetine]]{{·}} [[Mazindol]]{{·}} [[Nisoxetine]]{{·}} [[Reboxetine]]{{·}} [[Talopram]]{{·}} [[Talsupram]]{{·}} [[Tandamine]]{{·}} [[Viloxazine]] |
| group5 = <small>[[Dopamine reuptake inhibitor|Dopamine Reuptake Inhibitor]]s (DRIs)</small> | | group5 = <small>[[Dopamine reuptake inhibitor|Dopamine Reuptake Inhibitor]]s (DRIs)</small> | ||
| − | | list5 = [[Medifoxamine]] | + | | list5 = [[Medifoxamine]]{{·}} [[Vanoxerine]] |
| group6 = <small>[[Norepinephrine-dopamine reuptake inhibitor|Norepinephrine-Dopamine Reuptake Inhibitor]]s (NDRIs)</small> | | group6 = <small>[[Norepinephrine-dopamine reuptake inhibitor|Norepinephrine-Dopamine Reuptake Inhibitor]]s (NDRIs)</small> | ||
| − | | list6 = [[Amineptine]] | + | | list6 = [[Amineptine]]{{·}} [[Bupropion|Bupropion/Amfebutamone]]{{·}} [[Cilobamine]]{{·}} [[Manifaxine]]{{·}} [[Methylphenidate]]{{·}} [[Nomifensine]]{{·}} [[Radafaxine]]{{·}} [[Tametraline]] |
| group7 = <small>[[Norepinephrine-dopamine releasing agent|Norepinephrine-Dopamine Releasing Agent]]s (NDRAs)</small> | | group7 = <small>[[Norepinephrine-dopamine releasing agent|Norepinephrine-Dopamine Releasing Agent]]s (NDRAs)</small> | ||
| − | | list7 = [[Amphetamine]] | + | | list7 = [[Amphetamine]]{{·}} [[Befuraline]]{{·}} [[Lisdexamfetamine]]{{·}} [[Methamphetamine]]{{·}} [[Phenethylamine]]{{·}} [[Piberaline]]{{·}} [[Tranylcypromine]] |
| group8 = <small>[[Serotonin-norepinephrine-dopamine releasing agent|Serotonin-Norepinephrine-Dopamine Releasing Agent]]s (SNDRAs)</small> | | group8 = <small>[[Serotonin-norepinephrine-dopamine releasing agent|Serotonin-Norepinephrine-Dopamine Releasing Agent]]s (SNDRAs)</small> | ||
| − | | list8 = [[4-Methyl-AMT|4-Methyl-αMT]] | + | | list8 = [[4-Methyl-AMT|4-Methyl-αMT]]{{·}} [[alpha-Ethyltryptamine|αET/Etryptamine]]{{·}} [[alpha-Methyltryptamine|αMT/Metryptamine]] |
| group9 = <small>[[Selective serotonin reuptake enhancer|Selective Serotonin Reuptake Enhancer]]s (SSREs)</small> | | group9 = <small>[[Selective serotonin reuptake enhancer|Selective Serotonin Reuptake Enhancer]]s (SSREs)</small> | ||
| Line 38: | Line 38: | ||
| group10 = <small>Others</small> | | group10 = <small>Others</small> | ||
| − | | list10 = [[Indeloxazine]] | + | | list10 = [[Indeloxazine]]{{·}} [[Tramadol]]{{·}} [[Viqualine]] |
}} | }} | ||
| Line 47: | Line 47: | ||
| group1 = <small>[[Serotonin antagonist and reuptake inhibitor|Serotonin Antagonists and Reuptake Inhibitor]]s (SARIs)</small> | | group1 = <small>[[Serotonin antagonist and reuptake inhibitor|Serotonin Antagonists and Reuptake Inhibitor]]s (SARIs)</small> | ||
| − | | list1 = [[Etoperidone]] | + | | list1 = [[Etoperidone]]{{·}} [[Nefazodone]]{{·}} [[Trazodone]] |
| group2 = <small>[[Noradrenergic and specific serotonergic antidepressant|Noradrenergic and Specific Serotonergic Antidepressant]]s (NaSSAs)</small> | | group2 = <small>[[Noradrenergic and specific serotonergic antidepressant|Noradrenergic and Specific Serotonergic Antidepressant]]s (NaSSAs)</small> | ||
| − | | list2 = [[Esmirtazapine]] | + | | list2 = [[Esmirtazapine]]{{·}} [[Mianserin]]{{·}} [[Mirtazapine]]{{·}} [[Setiptiline|Setiptiline/Teciptiline]] |
| group3 = <small>[[Norepinephrine-dopamine disinhibitor|Norepinephrine-Dopamine Disinhibitor]]s (NDDIs)</small> | | group3 = <small>[[Norepinephrine-dopamine disinhibitor|Norepinephrine-Dopamine Disinhibitor]]s (NDDIs)</small> | ||
| Line 62: | Line 62: | ||
| group3 = [[Tricyclic antidepressant|Tricyclic]] and [[Tetracyclic antidepressant|Tetracyclic Antidepressant]]s (TCAs/TeCAs) | | group3 = [[Tricyclic antidepressant|Tricyclic]] and [[Tetracyclic antidepressant|Tetracyclic Antidepressant]]s (TCAs/TeCAs) | ||
| abbr3 = TCAs | | abbr3 = TCAs | ||
| − | | list3 = '''Tricyclics''': [[Amineptine]] | + | | list3 = '''Tricyclics''': [[Amineptine]]{{·}} [[Amitriptyline]]{{·}} [[Amitriptylinoxide]]{{·}} [[Azepindole]]{{·}} [[Butriptyline]]{{·}} [[Cianopramine]]{{·}} [[Clomipramine]]{{·}} [[Cotriptyline]]{{·}} [[Cyanodothiepin]]{{·}} [[Demexiptiline]]{{·}} [[Desipramine]]{{·}} [[Dibenzepine]]{{·}} [[Dimetacrine]]{{·}} [[Dosulepin|Dosulepin/Dothiepin]]{{·}} [[Doxepin]]{{·}} [[Fluotracen]]{{·}} [[Hepzidine]]{{·}} [[Homopipramol]]{{·}} [[Imipramine]]{{·}} [[Imipraminoxide]]{{·}} [[Intriptyline]]{{·}} [[Iprindole]]{{·}} [[Ketipramine]]{{·}} [[Litracen]]{{·}} [[Lofepramine]]{{·}} [[Lortalamine]]{{·}} [[Losindole]]{{·}} [[Mariptiline]]{{·}} [[Melitracen]]{{·}} [[Metapramine]]{{·}} [[Mezepine]]{{·}} [[Naranol]]{{·}} [[Nitroxazepine]]{{·}} [[Nortriptyline]]{{·}} [[Noxiptiline]]{{·}} [[Octriptyline]]{{·}} [[Opipramol]]{{·}} [[Pipofezine]]{{·}} [[Propizepine]]{{·}} [[Protriptyline]]{{·}} [[Quinupramine]]{{·}} [[Tampramine]]{{·}} [[Tianeptine]]{{·}} [[Tienopramine]]{{·}} [[Trimipramine]]; '''Tetracyclics''': [[7-Hydroxyamoxapine|7-OH-Amoxapine]]{{·}} [[Amoxapine]]{{·}} [[Ciclazindol]]{{·}} [[Esmirtazapine]]{{·}} [[Loxapine]]{{·}} [[Maprotiline]]{{·}} [[Mazindol]]{{·}} [[Mianserin]]{{·}} [[Mirtazapine]]{{·}} [[Oxaprotiline]]{{·}} [[Setiptiline|Setiptiline/Teciptiline]] |
| group4 = [[Monoamine oxidase inhibitor|Monoamine Oxidase Inhibitors]] (MAOIs) | | group4 = [[Monoamine oxidase inhibitor|Monoamine Oxidase Inhibitors]] (MAOIs) | ||
| abbr4 = MAOIs | | abbr4 = MAOIs | ||
| − | | list4 = '''Nonselective:''' ''Irreversible:'' [[Benmoxin]] | + | | list4 = '''Nonselective:''' ''Irreversible:'' [[Benmoxin]]{{·}} [[Echinopsidine]]{{·}} [[Iproclozide]]{{·}} [[Iproniazid]]{{·}} [[Isocarboxazid]]{{·}} [[Mebanazine]]{{·}} [[Metfendrazine]]{{·}} [[Nialamide]]{{·}} [[Octamoxin]]{{·}} [[Phenelzine]]{{·}} [[Pheniprazine]]{{·}} [[Phenoxypropazine]]{{·}} [[Pivalylbenzhydrazine]]{{·}} [[Safrazine]]{{·}} [[Tranylcypromine]]; ''Reversible:'' [[Caroxazone]]{{·}} [[Paraxazone]]; '''MAO<sub>A</sub>-Selective:''' ''Irreversible:'' [[Clorgyline]]; ''Reversible:'' [[Amiflamine]]{{·}} [[Bazinaprine]]{{·}} [[Befloxatone]]{{·}} [[Befol]]{{·}} [[Brofaromine]]{{·}} [[Cimoxatone]]{{·}} [[Esuperone]]{{·}} [[Harmala alkaloid|Harmala Alkaloid]]s ([[Harmine]], [[Harmaline]], [[Tetrahydroharmine]], [[Harmala alkaloid#Chemical Forms|Harman]], [[Norharman]], etc){{·}} [[Methylene blue|Methylene Blue]]{{·}} [[Metralindole]]{{·}} [[Minaprine]]{{·}} [[Moclobemide]]{{·}} [[Pirlindole]]{{·}} [[Sercloremine]]{{·}} [[Tetrindole]]{{·}} [[Toloxatone]]{{·}} [[Tyrima]]; '''MAO<sub>B</sub>-Selective:''' ''Irreversible:'' [[Ladostigil]]{{·}} [[Mofegiline]]{{·}} [[Pargyline]]{{·}} [[Rasagiline]]{{·}} [[Selegiline]]; ''Reversible:'' [[Lazabemide]]{{·}} [[Milacemide]] |
| group5 = [[Azapirone]]s and Other [[5-HT1A receptor|5-HT<sub>1A</sub> Receptor]] [[Serotonin receptor agonist|Agonist]]s | | group5 = [[Azapirone]]s and Other [[5-HT1A receptor|5-HT<sub>1A</sub> Receptor]] [[Serotonin receptor agonist|Agonist]]s | ||
| abbr5 = AZPs | | abbr5 = AZPs | ||
| − | | list5 = [[Alnespirone]] | + | | list5 = [[Alnespirone]]{{·}} [[Aripiprazole]]{{·}} [[Befiradol]]{{·}} [[Buspirone]]{{·}} [[Eptapirone]]{{·}} [[Flesinoxan]]{{·}} [[Flibanserin]]{{·}} [[Gepirone]]{{·}} [[Ipsapirone]]{{·}} [[Oxaflozane]]{{·}} [[Tandospirone]]{{·}} [[Vilazodone]]{{·}} [[Zalospirone]] |
| group6 = [[Dietary supplement|Dietary Supplement]]s ([[Vitamin]]s, [[Mineral]]s, [[Amino acid|Amino Acid]]s, etc) | | group6 = [[Dietary supplement|Dietary Supplement]]s ([[Vitamin]]s, [[Mineral]]s, [[Amino acid|Amino Acid]]s, etc) | ||
| abbr6 = SUPPs | | abbr6 = SUPPs | ||
| − | | list6 = [[Ascorbic acid|Ascorbic Acid]] (Vitamin C) | + | | list6 = [[Ascorbic acid|Ascorbic Acid]] (Vitamin C){{·}} [[Fish oil|Fish Oil]]{{·}} [[Folic acid|Folic Acid]] (Vitamin B<sub>9</sub>){{·}} [[L-5-Hydroxytryptophan|L-5-HTP]] (Oxitriptan){{·}} [[L-DOPA]] (Levodopa){{·}} [[L-Methionine]]{{·}} [[L-Phenylalanine]]{{·}} [[L-Tryptophan]]{{·}} [[L-Tyrosine]]{{·}} [[Lithium]]{{·}} [[Magnesium]]{{·}} [[Melatonin]]{{·}} [[Niacin]]/[[Niacinamide]] (Vitamin B<sub>3</sub>){{·}} [[Omega-3 fatty acid|Omega-3 Fatty Acid]]s{{·}} [[Pyridoxine]] (Vitamin B<sub>6</sub>){{·}} [[Rubidium]]{{·}} [[S-Adenosyl-L-methionine|SAMe]]{{·}} [[Zinc]] |
| group7 = [[Research chemical|Research Compound]]s and Miscellaneous Agents | | group7 = [[Research chemical|Research Compound]]s and Miscellaneous Agents | ||
| Line 81: | Line 81: | ||
| group1 = <small>[[5-HT4 receptor|5-HT<sub>4</sub>R]] [[Serotonin receptor agonist|Agonist]]s</small> | | group1 = <small>[[5-HT4 receptor|5-HT<sub>4</sub>R]] [[Serotonin receptor agonist|Agonist]]s</small> | ||
| − | | list1 = [[RS-67,333]] | + | | list1 = [[RS-67,333]]{{·}} [[SL65.0155]] |
| group2 = <small>[[5-HT7 receptor|5-HT<sub>7</sub>R]] [[Serotonin receptor antagonist|Antagonist]]s</small> | | group2 = <small>[[5-HT7 receptor|5-HT<sub>7</sub>R]] [[Serotonin receptor antagonist|Antagonist]]s</small> | ||
| Line 87: | Line 87: | ||
| group3 = <small>[[Voltage-dependent calcium channel|α2δ-VDCC]] [[Calcium channel blocker|Blocker]]s</small> | | group3 = <small>[[Voltage-dependent calcium channel|α2δ-VDCC]] [[Calcium channel blocker|Blocker]]s</small> | ||
| − | | list3 = [[Gabapentin]] | + | | list3 = [[Gabapentin]]{{·}} [[Pregabalin]] |
| group4 = <small>[[Beta-3 adrenergic receptor|β<sub>3</sub>-Adrenoceptor]] [[Adrenergic agonist|Agonist]]s | | group4 = <small>[[Beta-3 adrenergic receptor|β<sub>3</sub>-Adrenoceptor]] [[Adrenergic agonist|Agonist]]s | ||
| − | | list4 = [[Amibegron]] | + | | list4 = [[Amibegron]]{{·}} [[Solabegron]] |
| group5 = <small>[[Sigma receptor|σ<sub>1</sub>R]] [[Agonist]]s</small> | | group5 = <small>[[Sigma receptor|σ<sub>1</sub>R]] [[Agonist]]s</small> | ||
| Line 96: | Line 96: | ||
| group6 = <small>[[CB1 receptor|CB<sub>1</sub>R]] [[Cannabinoid|Agonist]]s | | group6 = <small>[[CB1 receptor|CB<sub>1</sub>R]] [[Cannabinoid|Agonist]]s | ||
| − | | list6 = [[Nabilone]] | + | | list6 = [[Nabilone]]{{·}} [[Tetrahydrocannabinol]]/[[Dronabinol]] |
| group7 = <small>[[Catechol O-methyltransferase|COMT]] [[COMT inhibitor|Inhibitor]]s | | group7 = <small>[[Catechol O-methyltransferase|COMT]] [[COMT inhibitor|Inhibitor]]s | ||
| − | | list7 = [[Entacapone]] | + | | list7 = [[Entacapone]]{{·}} [[Tolcapone]] |
| group8 = <small>[[Corticotropin releasing hormone receptor 1|CRF<sub>1</sub>R]] [[Corticotropin releasing hormone antagonist|Antagonist]]s</small> | | group8 = <small>[[Corticotropin releasing hormone receptor 1|CRF<sub>1</sub>R]] [[Corticotropin releasing hormone antagonist|Antagonist]]s</small> | ||
| − | | list8 = [[Antalarmin]] | + | | list8 = [[Antalarmin]]{{·}} [[CP-154,526]]{{·}} [[Pexacerfont]]{{·}} [[Pivagabine]] |
| group9 = <small>[[D2 receptor|D<sub>2</sub>]]/[[D3 receptor|D<sub>3</sub>]][[Autoreceptor|AR]] [[Dopamine receptor antagonist|Antagonist]]s</small> | | group9 = <small>[[D2 receptor|D<sub>2</sub>]]/[[D3 receptor|D<sub>3</sub>]][[Autoreceptor|AR]] [[Dopamine receptor antagonist|Antagonist]]s</small> | ||
| − | | list9 = [[Amisulpride]] | + | | list9 = [[Amisulpride]]{{·}} [[Sulpiride]] |
| group10 = <small>[[D2 receptor|D<sub>2</sub>]]/[[D3 receptor|D<sub>3</sub>]]/[[D4 receptor|D<sub>4</sub>]][[Dopamine receptor agonist|R Agonist]]s</small> | | group10 = <small>[[D2 receptor|D<sub>2</sub>]]/[[D3 receptor|D<sub>3</sub>]]/[[D4 receptor|D<sub>4</sub>]][[Dopamine receptor agonist|R Agonist]]s</small> | ||
| − | | list10 = [[Piribedil]] | + | | list10 = [[Piribedil]]{{·}} [[Pramipexole]]{{·}} [[Ropinirole]]{{·}} [[Rotigotine]]{{·}} [[Roxindole]] |
| group11 = <small>[[delta-opioid receptor|DOR]] [[Opioid|Agonist]]s</small> | | group11 = <small>[[delta-opioid receptor|DOR]] [[Opioid|Agonist]]s</small> | ||
| − | | list11 = [[BU-48]] | + | | list11 = [[BU-48]]{{·}} [[Buprenorphine]]{{·}} [[BW373U86]]{{·}} [[DPI-287]]{{·}} [[Heroin]]{{·}} [[Kratom]]{{·}} [[SNC-80]] |
| group12 = <small>[[Enkephalinase]] [[Enzyme inhibitor|Inhibitor]]s</small> | | group12 = <small>[[Enkephalinase]] [[Enzyme inhibitor|Inhibitor]]s</small> | ||
| − | | list12 = [[Phenylalanine|D-Phenylalanine]] | + | | list12 = [[Phenylalanine|D-Phenylalanine]]{{·}} [[RB-101]] |
| group13 = <small>[[Fatty acid amide hydrolase|FAAH]] [[Enzyme inhibitor|Inhibitor]]s</small> | | group13 = <small>[[Fatty acid amide hydrolase|FAAH]] [[Enzyme inhibitor|Inhibitor]]s</small> | ||
| − | | list13 = [[Acetaminophen]]/[[Paracetamol]] | + | | list13 = [[Acetaminophen]]/[[Paracetamol]]{{·}} [[AM404|AM-404]]{{·}} [[URB597|URB-597]] |
| group14 = <small>[[kappa-opioid receptor|KOR]] [[Opioid|Antagonist]]s</small> | | group14 = <small>[[kappa-opioid receptor|KOR]] [[Opioid|Antagonist]]s</small> | ||
| − | | list14 = [[5'-Guanidinonaltrindole|5-GNTI]] | + | | list14 = [[5'-Guanidinonaltrindole|5-GNTI]]{{·}} [[Buprenorphine]]{{·}} [[JDTic]]{{·}} [[Norbinaltorphimine]] |
| group15 = <small>[[mu-opioid receptor|MOR]] [[Opioid|Agonist]]s | | group15 = <small>[[mu-opioid receptor|MOR]] [[Opioid|Agonist]]s | ||
| − | | list15 = [[Buprenorphine]] | + | | list15 = [[Buprenorphine]]{{·}} [[Codeine]]{{·}} [[Dextropropoxyphene]]{{·}} [[Dihydrocodeine]]{{·}} [[Fentanyl]]{{·}} [[Heroin]]{{·}} [[Hydrocodone]]{{·}} [[Hydromorphone]]{{·}} [[Kratom]]{{·}} [[Methadone]]{{·}} [[Morphine]]{{·}} [[Opium]]{{·}} [[Oxycodone]]{{·}} [[Oxymorphone]]{{·}} [[Pethidine|Pethidine/Meperidine]]{{·}} [[Tapentadol]]{{·}} [[Tramadol]] |
| group16 = <small>[[MT1 receptor|MT<sub>1</sub>]]/[[MT2 receptor|MT<sub>2</sub>R]] [[Agonist]]s | | group16 = <small>[[MT1 receptor|MT<sub>1</sub>]]/[[MT2 receptor|MT<sub>2</sub>R]] [[Agonist]]s | ||
| − | | list16 = [[Agomelatine]] | + | | list16 = [[Agomelatine]]{{·}} [[Melatonin]]{{·}} [[Ramelteon]]{{·}} [[Tasimelteon]] |
| group17 = <small>[[NK1 receptor|NK<sub>1</sub>R]] [[NK1 receptor antagonist|Antagonist]]s</small> | | group17 = <small>[[NK1 receptor|NK<sub>1</sub>R]] [[NK1 receptor antagonist|Antagonist]]s</small> | ||
| − | | list17 = [[Aprepitant]] | + | | list17 = [[Aprepitant]]{{·}} [[Casopitant]]{{·}} [[Fosaprepitant]]{{·}} [[L-733,060]]{{·}} [[Maropitant]]{{·}} [[Vestipitant]] |
| group18 = <small>[[NMDA receptor|NMDAR]] [[NMDA receptor antagonist|Antagonist]]s</small> | | group18 = <small>[[NMDA receptor|NMDAR]] [[NMDA receptor antagonist|Antagonist]]s</small> | ||
| − | | list18 = [[Dextromethorphan]] | + | | list18 = [[Dextromethorphan]]{{·}} [[Ketamine]]{{·}} [[Magnesium]]{{·}} [[Memantine]]{{·}} [[Zinc]] |
| group19 = <small>[[PDE4]] [[Phosphodiesterase inhibitor|Inhibitor]]s</small> | | group19 = <small>[[PDE4]] [[Phosphodiesterase inhibitor|Inhibitor]]s</small> | ||
| − | | list19 = [[Mesembrine]] ([[Sceletium tortuosum|Kanna]]) | + | | list19 = [[Mesembrine]] ([[Sceletium tortuosum|Kanna]]){{·}} [[Rolipram]] |
| group20 = <small>[[TRPC6]] [[Agonist|Activator]]s</small> | | group20 = <small>[[TRPC6]] [[Agonist|Activator]]s</small> | ||
| − | | list20 = [[Adhyperforin]] ([[Hypericum perforatum|St. John's Wort]]) | + | | list20 = [[Adhyperforin]] ([[Hypericum perforatum|St. John's Wort]]){{·}} [[Hyperforin]] ([[Hypericum perforatum|St. John's Wort]]) |
}} | }} | ||
| Line 146: | Line 146: | ||
| − | }} | + | }}<noinclude> |
| − | <noinclude> | ||
| − | + | {{Collapsible sections option | list = "RIEAs", "RARIs", ""TCAs", "MAOIs", "AZPs", "SUPPs" or "MISCs"}} | |
[[Category:Drug templates|{{PAGENAME}}]] | [[Category:Drug templates|{{PAGENAME}}]] | ||
Revision as of 08:19, 24 June 2010
Template:Navbox with collapsible sections
How to manage this template's collapsible groups/sections option
- This template includes collapsible groups/sections. When it first appears, one of these groups/sections may be set to be visible ("expanded") while the others remain hidden ("collapsed") apart from their titlebars. To achieve this, include the parameter
|namewhere name is one of the following words that identify the groups/sections (omit any speech or quotation marks): "RIEAs", "RARIs", ""TCAs", "MAOIs", "AZPs", "SUPPs" or "MISCs"
fr:Modèle:Antidépresseurs hu:Sablon:Antidepresszánsok ru:Шаблон:Антидепрессанты